Filing Details
- Accession Number:
- 0001213900-25-061752
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-07 16:03:16
- Reporting Period:
- 2025-07-03
- Filing Date:
- 2025-07-07
- Accepted Time:
- 2025-07-07 16:03:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1821586 | Moonlake Immunotherapeutics | MLTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772130 | Catherine Moukheibir | C/O Moonlake Immunotherapeutics Dorfstrasse 29 Zug V8 6300 | Yes | No | No | No |
Transaction Summary
| Sold: | 23,500 shares | Avg. Price: $48.79 | Total Value: $1,146,565.00 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Acquisiton | 2025-07-03 | 23,500 | $0.00 | 23,500 | No | 4 | M | Direct | |
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Disposition | 2025-07-03 | 23,500 | $48.79 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares, Par Value $0.0001 Per Share | Option to Buy | Disposition | 2025-07-03 | 23,500 | $0.00 | 23,500 | $12.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,500 | 2032-04-06 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $48.59 to $49.01. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- These options are fully vested.
Billionaire Hedge Funds
